Therapeutics News and Research

RSS
Cytrx to submit revised protocol for arimoclomol Phase IIb clinical trial

Cytrx to submit revised protocol for arimoclomol Phase IIb clinical trial

Preliminary results of Phase III Gvhd trials announced by Osiris Therapeutics

Preliminary results of Phase III Gvhd trials announced by Osiris Therapeutics

Opexa Therapeutics' ongoing development program for Tovaxin to be presented

Opexa Therapeutics' ongoing development program for Tovaxin to be presented

Proteostasis Therapeutics to use GeneGo's MetaCore integrated software

Proteostasis Therapeutics to use GeneGo's MetaCore integrated software

NanoViricides' drug pipeline to be discussed at NanoBusiness2009

NanoViricides' drug pipeline to be discussed at NanoBusiness2009

Opexa Therapeutics releases Phase IIb TERMS clinical study results

Opexa Therapeutics releases Phase IIb TERMS clinical study results

Patient enrollment for Phase 2b study of PRX302 completed by Protox Therapeutics

Patient enrollment for Phase 2b study of PRX302 completed by Protox Therapeutics

Small molecule inhibitors could create new combination therapies

Small molecule inhibitors could create new combination therapies

Aptamer nanoflares for molecular detection in living cells

Aptamer nanoflares for molecular detection in living cells

FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone

FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone

Securities class action lawsuit filed against Repros Therapeutics

Securities class action lawsuit filed against Repros Therapeutics

Dr Lluis Quintana-Murci from the Institut Pasteur in France honoured with the Debiopharm Life Sciences Award

Dr Lluis Quintana-Murci from the Institut Pasteur in France honoured with the Debiopharm Life Sciences Award

Systematic method for improving the stability of antibodies

Systematic method for improving the stability of antibodies

NCI renews SPORE grant for the diagnosis and treatment of ovarian cancer

NCI renews SPORE grant for the diagnosis and treatment of ovarian cancer

Optimized turmeric extracts may prevent memory loss

Optimized turmeric extracts may prevent memory loss

Corporate restructuring announced by Akela Pharma to achieve several operational objectives

Corporate restructuring announced by Akela Pharma to achieve several operational objectives

Celgene to collaborate with PTC on advancing drug discovery efforts

Celgene to collaborate with PTC on advancing drug discovery efforts

PTC Therapeutics collaborates with Roche for developing bioavailable small molecules

PTC Therapeutics collaborates with Roche for developing bioavailable small molecules

Biogen Idec's MS franchise to present at the 25th Congress of ECTRIMS

Biogen Idec's MS franchise to present at the 25th Congress of ECTRIMS

National Cancer Institute awards grant to Receptor Logic for breast cancer research

National Cancer Institute awards grant to Receptor Logic for breast cancer research